Infectious Disease Diagnostics Market
Infectious Disease Diagnostics Market - Global Industry Assessment & Forecast
#
Pages:
132
2022
Mar - 2022
VMR-1376
Segments Covered
By
Product Reagents, Kits, and Consumables, Instruments, Software & Services
-
By
Type of Testing Laboratory Testing, POC Testing
-
By
Technology Immunodiagnostics, Clinical Microbiology , PCR , INAAT , DNA Sequencing & NGS , DNA Microarrays , Other technologies
-
By
Disease Type COVID-19, HIV , HAIs , Hepatitis , CT/NG , HPV , TB , Influenza , Other Infectious Diseases
-
By
End User Diagnostic Laboratories, Hospitals & Clinics , Academic Research Institutes , Other End Users
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 29632.56 Million |
 Revenue 2030:
|
USD 49041.76 Million |
 Revenue CAGR
(2023 - 2030): |
6.50% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Infectious Disease Diagnostics Market
Market Synopsys
Global Infectious Disease Diagnostics market is valued at USD 29632.56 Million in 2022 and is projected to reach a value of USD 49041.76 Million by 2030 at a CAGR of 6.50% over the forecast period. The epidemiological weight of infectious diseases like extreme intense respiratory condition (SARS), Middle East respiratory disorder (MERS), Ebola, chikungunya, avian influenza, pig influenza, and Zika has opened entryway for their initial conclusion and avoidance. Essentially, current episode of COVID-19 pandemic has enormously expanded the interest for different POC analytic packs for early analysis and control the spread of COVID. Further, the developing mindfulness for early location utilizing explicit symptomatic tests, development in subsidizing for research on irresistible illness diagnostics, and change in center from concentrated labs to decentralized reason behind care testing administrations are relied upon to impel the development of the worldwide irresistible sickness diagnostics market. Nonetheless, negative and deficient repayment situation is relied upon to hamper the development of the irresistible illness diagnostics market.
Diagnostics assume an imperative part in deciding the bearing of any clinical treatment. While irresistible sicknesses diagnostics help in diagnosing illnesses caused because of pathogenic disease. The world of diagnostics is developing quickly and the global market for Infectious Disease Diagnostics is developing at a consistent speed in the next upcoming years.
Infectious Disease Diagnostics Market Size, 2022 To 2030 (USD Million)
AI (GPT) is here !!! Ask questions about Infectious Disease Diagnostics Market
Market Segmentation:
The global Infectious Disease Diagnostics market is segmented on the basis of product, type of testing, technology, disease type and end use. Based on product, the market is segmented as reagents, kits & consumables; instruments; and software & services. By type, the market is segmented into laboratory testing and POC testing. By technology, the market is segmented into immunodiagnostics, clinical microbiology, PCR, INAAT, DNA sequencing & NGS, DNA microarrays, other technologies. By disease type, the market is segmented into Covid-19, HIV, HAIs, Hepatitis, CT/NG, HPV, TB, Influenza, other infectious diseases. By end user, the market is segmented into diagnostic laboratories, hospitals & clinics, academic research institutes, and other end users.
Report Coverage & Deliverables
- Competitive benchmarking
- Historical data & forecasts
- Company revenue shares
- Regional opportunities
- Latest trends & dynamics
- Power BI Report (Dashboard)
Below tree is interactive. You can click the nodes to get more information.
Based on product, reagents, kits, and consumables segment holds a major revenue share in the Infectious Disease Diagnostics market
In 2020, the reagents, kits and consumables segment holds a major revenue share in the target market. Increasing demand and purchase of these products owing to their frequent use augments the growth of this segment.
Based on type of testing, POC testing segment grows at a rapid pace in the Infectious Disease Diagnostics market over the forecast period
The POC testing segments is projected to grow at a rapid CAGR in the target market over the forecast period, owing to increasing prevalence of infectious diseases.
Based on technology, immunodiagnostics accounted a major share in the market
In 2020, the immunodiagnostics segment is expected to hold for a major share in terms of revenue in the target market. This can be attributed to the increased use of immunoassays in COVID-19 testing, POC infectious disease testing, the development of novel immunodiagnostic tests, and the rising trend in automation.
Based on diseases type, the hepatitis holds the largest share of the global Infectious Disease Diagnostics market
The hepatitis sicknesses fragment is assessed to hold the biggest portion of the global Infectious Disease Diagnostics market in 2020. Expanding number of blood bonding and gifts, expanding commonness of hepatitis B and C contaminations, rising vulnerability of the geriatric populace, developing mindfulness among the populace, and advantages presented by point of care instruments and units are relied upon to push the development of this section.
Based on end user, hospitals & clinics segment accounts for largest revenue share in the Infectious Disease Diagnostics market over the forecast period
The hospitals & clinics segments is expected to account for largest revenue share in the target market over the forecast period, owing to increasing number of infectious diseases.
In the region, the Asia Pacific Infectious Disease Diagnostics market holds significant revenue share
North America Infectious Disease Diagnostics market is expected to hold significant revenue share in terms of revenue, whereas, Asia Pacific market is projected to grow at a rapid CAGR during the forecast period. The variables driving the growth of the Infectious Disease Diagnostics market in Asia Pacific are rapid urbanization, expanding speculation by healthcare providers for infrastructure improvement, the need to treat infectious diseases, and government efforts to further develop the availability of symptomatic management through the creation of programs or detection of infectious diseases at an early stage.
Competitive Landscape
The key players in the Infectious Disease Diagnostics market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (US), bioMérieux SA (France), Danaher Corporation (US), Hologic, Inc. (US), Quidel Corporation (US), Siemens Healthineers AG (Germany), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), QIAGEN (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Ortho Clinical Diagnostics (US), Sysmex Corporation (Japan), Luminex Corporation (US), Genetic Signatures (Australia), Meridian Bioscience (US), OraSure Technologies (US), Chembio Diagnostic Systems, Inc. (US), Trinity Biotech Plc. (Ireland), Seegene Inc. (South Korea), ELITechGroup (France), Co-Diagnostics, Inc. (US), Epitope Diagnostics, Inc. (US), Meril Life Sciences Pvt. Ltd. (India), Trivitron Healthcare (India), InBios International, Inc. (US), and ABACUS Diagnostica Oy (Finland).
Infectious Disease Diagnostics Market is Segmented as Follows:
Parameter
Details
Segments Covered
Regions & Countries Covered
Companies Covered
Report Coverage
Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST
analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market
attractiveness analysis by segments and North America, company market share analysis, and COVID-19
impact analysis
Pricing and purchase options
Avail of customized purchase options to meet your exact research needs. Explore purchase options
Infectious Disease Diagnostics Market is Tabulated as Follows:
Vantage Market
Research | 16-Mar-2022
FAQ
Frequently Asked Question
What is the global demand for Infectious Disease Diagnostics in terms of revenue?
-
The global Infectious Disease Diagnostics valued at USD 29632.56 Million in 2022 and is expected to reach USD 49041.76 Million in 2030 growing at a CAGR of 6.50%.
Which are the prominent players in the market?
-
The prominent players in the market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd(Switzerland), bioMérieux SA (France), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Quidel Corporation(US), Hologic, Inc. (US), Siemens Healthineers AG (Germany), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), QIAGEN (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics (US), Luminex Corporation (US), Meridian Bioscience (US), Genetic Signatures (Australia), OraSure Technologies (US), Trinity Biotech Plc. (Ireland), Chembio Diagnostic Systems, Inc. (US), Seegene Inc. (South Korea), Co-Diagnostics, Inc. (US), ELITechGroup (France), Epitope Diagnostics, Inc. (US), Trivitron Healthcare (India), Meril Life Sciences Pvt. Ltd. (India), InBios International, Inc. (US), and ABACUS Diagnostica Oy (Finland)..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 6.50% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Infectious Disease Diagnostics include
- increasing prevalence of infectious diseases
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Infectious Disease Diagnostics in 2022.
